Crowe advises Wellma on merger with PlantaCorp

Wellma, a portfolio company of Swedish company builder Systematic Growth, joins forces with PlantaCorp - a German-based private label and contract manufacturer of liposomal nutritional supplements.

PlantaCorp is a leading German-based research and manufacturing company specializing in liposomal technology in liquid form. It provides B2B nutraceutical customers with the technology and expertise to develop their own liposomal formulations with high bioavailability. With a clear focus on advanced research, quality and state-of-the-art manufacturing, PlantaCorp supports brands in producing effective and scientifically validated products for their end customers.

Wellma is a European market leader in the development and production of nutraceuticals and pharmaceuticals with production sites across the European continent, a global customer base and rapid growth. With a focus on quality, flexibility and innovation, Wellma provides B2B development and production services to leading players in the nutraceuticals and pharmaceuticals sector.

The collaboration with PlantaCorp and the associated bundling of competencies strengthens Wellma's position in the food supplement and pharmaceutical industry.

The Crowe BPG team (crowe-bpg.de), which was responsible for the financial due diligence and economic advice, consisted of Andreas Hoffmann, WP and Partner, and Philipp Jans, Senior Associate (Financial). The tax due diligence and tax SPA advice for the transaction was provided by Dr. Philipp Kruse (tax advisor and managing director).
 

Source: Deal Advisors by Majunke